Table 2 Surgical treatment and complications
| Characteristics |
All patients 23 (100%)a |
NR 7 (30%) |
PR 10 (43%) |
TR 6 (26%) | p valueb |
|---|---|---|---|---|---|
| Radiotherapy | 0.822 | ||||
| 45 Gy | 1 (4) | 0 | 1 (10) | 0 | |
| 45 Gy + 5.4 Gy | 21 (91) | 6 (86) | 9 (90) | 6 (100) | |
| 50.5 Gy | 1 (4) | 1 (14) | 0 | 0 | |
| Chemotherapy | 3.2e−05 | ||||
| Xeloda® | 22 (96) | 7 (100) | 9 (90) | 6 (100) | |
| 5-FU | 1 (4) | 0 | 1 (10) | 0 | |
| Radiodermatitis | 0.962 | ||||
| − | 7 (30) | 2 (29) | 3 (30) | 2 (33) | |
| Non-severe | 13 (57) | 4 (57) | 5 (50) | 4 (67) | |
| Severe | 3 (13) | 1 (14) | 2 (20) | 0 | |
| Proctitis | 0.211 | ||||
| + | 11 (48) | 2 (29) | 7 (70) | 2 (33) | |
| − | 12 (52) | 5 (71) | 3 (30) | 4 (67) | |
| Colitis | 1 | ||||
| + | 0 | 0 | 0 | 0 | |
| − | 23 (100) | 7 (100) | 10 (100) | 6 (100) | |
| Mucositis | 1 | ||||
| + | 0 | 0 | 0 | 0 | |
| − | 23 (100) | 7 (100) | 10 (100) | 6 (100) | |
| Surgical resection type | 0.004 | ||||
| Low anterior | 17 (74) | 7 (100) | 8 (80) | 2 (33) | |
| Abdomino-perineal | 2 (9) | 0 | 2 (20) | 0 | |
| Endo-anal | 1 (4) | 0 | 0 | 1 (17) | |
| Refused | 3 (13) | 0 | 0 | 3 (50) | |
| Surgery delay | |||||
| Median | 8.6 ± 2.8 | 9.3 ± 2.7 | 8.3 ± 3.1 | 8.1 ± 2.6 | |
| Range | 1.4–13.1 | 5.3–13.1 | 1.4–12.9 | 6.0–11.0 |